UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940 |
|
| ||||||||||||||||||||||||||||||
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | SEC 1473 (7-02) | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. |
1. Title of Derivative Security (Instr. 4) |
2. Date Exercisable and Expiration Date (Month/Day/Year) |
3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) |
4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5) |
6. Nature of Indirect Beneficial Ownership (Instr. 5) |
||
Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
Options | 09/02/2010 | 09/01/2020 | Common Stock | 5,218 (2) | $ 0.48 | D | Â |
Options | 04/12/2011 | 04/11/2021 | Common Stock | 16,305 (3) | $ 0.64 | D | Â |
Options | 04/29/2013 | 04/28/2023 | Common Stock | 5,435 (4) | $ 8.81 | D | Â |
Series B Preferred Stock | Â (5) | Â (5) | Common Stock | 1,160 (5) | $ (5) | D | Â |
Reporting Owner Name / Address | Relationships | |||
Director | 10% Owner | Officer | Other | |
Belsky Paul C/O 100 EUROPA DRIVE CHAPEL HILL, NC 27517 |
 X |  |  |  |
/s/ Paul Belsky | 07/23/2013 | |
**Signature of Reporting Person | Date |
* | If the form is filed by more than one reporting person, see Instruction 5(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
(1) | Does not include shares of common stock that will be issued upon consummation of the Company's initial public offering resulting in net proceeds of at least $15 million in lieu of Series B-2 Preferred Stock that was committed to be purchased upon receipt of certain grant funding and the shares underlying warrants to be issued at such time. |
(2) | Fully Vested. |
(3) | This option is currently vested and exercisable as to 9,172 shares. 1,019 shares vest and become exercisable at the end of each quarter with the last options vesting on March 31, 2015. |
(4) | No options are currently vested and exercisable shares. 226 shall vest and become exercisable ratably over two years with the last option vesting on July 29, 2015. |
(5) | The Series B Preferred Stock automatically converts into shares of common stock to be issued upon consummation of the Company's initial public offering resulting in net proceeds of at least $15 million. |